Skip to main content

Table 6 Efficacy outcomes in the Modified ITT and protocol populations

From: The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial

Outcomes in modified ITT

Steroid + Azithromycin (N = 116)

Azithromycin (N = 110)

Lopinavir/Ritonavir (N = 110)

Total (N = 336)

P value

Death

4

6

6

16

Chi2 = 0.67; df = 1; P = 0.71

Admission to ICU

5

6

7

18

Chi2 = 0.47; df = 1; P = 0.79

Intubation declared

2

1

3

6

Chi2 = 1.14; df = 1; P = 0.57

Outcomes in per-protocol

Steroid + Azithromycin (N = 64)

Azithromycin (N = 51)

Lopinavir/Ritonavir (N = 51)

Total (N = 166)

P value

Death

2

1

3

6

Chi2 = 1.20; df = 1; P = 0.55

Admission to ICU

1

3

4

8

Chi2 = 2.62; df = 1; P = 0.27

Intubation declared

0

1

2

3

Chi2 = 0.89; df = 1; P = 0.64